Imagine the day when you and your patient can view their health metrics on one digital platform. The day when one-dimensional testing – blood, genetics, and microbiome – are combined to provide a whole-body health picture – both inside and out. A day when all this testing is done through user-friendly, affordable, at-home test kits that offer the most advanced analytical technology. Well, that day is here.
Episode 58: SPONSORED Biocidin – Borrelia Research and Clinical Strategies using Botanical Antimicrobials
Lyme disease (and co-infections) can be tough to treat. The Lyme spirochete, Borrelia burgdorferi, has adopted loads of devilishly clever cloaking devices – from thriving in biofilm to existing in pleomorphic forms – to ensure survival despite aggressive treatment. Enter botanical therapy. With or without concurrent antibiotics, botanical combinations are an essential component of the FxMed clinician’s toolkit.
Episode 56: SPONSORED Advances in Stool Testing: The GI-MAP™ GI-Microbial Assay Plus with Tony Hoffman
I had loads of fun taking a tour through the wonderment of DSL GI MAP test today with Tony Hoffman, CEO of DSL (and longtime friend of mine!). DSL’s GI MAP stool test is, as CEO Tony Hoffman states, “a clinician diagnostic tool,” not a microbiome test. Yes, of course the GI MAP looks at the microbiome, but it’s not a broad sweep of the myriad bugs taking up residence.
In today’s podcast, I’m talking with long time integrative medical clinician and anti-aging expert Lynne Mielke, MD about her approach to bioidentical hormones and why the Precision Analytical DUTCH is her go-to test for assessing biHRT response.
Episode 46: Endotoxemia: The Underlying Reason Most of Your Patients Need Immunoglobulins with Dr. Jill Carnahan
In my podcast with Dr. Jill Carnahan this month, she unleashes a torrent of compelling science and clinical savvy on all things endotoxemia. From heart disease and diabetes to autoimmunity (genetic or acquired) and mast cell activation, Dr. Carnahan is clear that pathological intestinal permeability (she discusses testing, but at this point in her career believes most everyone who sees her with chronic disease has IP) drives inflammation by allowing excess microbial endotoxins- primarily as lipopolysaccharide (LPS) – to enter circulation.
Commentary From Cass Nelson-Dooley (Podcast on Oral Microbiome): This a great study about the Human Microbiome Project comparing microbes through ALL points of the GI tract. It revealed some interesting things about normal, healthy subjects. For instance, they have oral bacterial pathogens, but no disease! This finding disputes the one bug-one disease paradigm (Koch’s Postulates). …
Clinicians, if you read anything today, read this: A case of total body contact dermatitis of unknown etiology, hives and dermatographism. Ellen found my practice after listening to a podcast I did on allergic disease with Dr. Amy Meyers for her Autoimmune Summit. It’s at times like these that I’m glad I do outreach of…
Dr. Richard S. Lord, nutritional biochemist extraordinaire and Chief Science Officer at Metametrix Clinical Laboratory (now Genova) recently retired after 25 years. Richard was the director of the Medical Education team when I was in Atlanta at the lab. Richard was and continues to be, my teacher.